Allylbenzene
Bluelighter
- Joined
- Jul 25, 2025
- Messages
- 987
This article looks at how methadone affects different types of cells including those which are still developing (ie baby) but also mature cells (ie adults). Here's a few excerpts with the relevant parts highlighted.
And for adults:
Technical part:
Conclusion part:
(original study)
Methadone is a synthetic long-acting opioid that is increasingly used in the replacement therapy of opioid-addicted patients, including pregnant women. However, methadone therapy in this population poses challenges, as it induces cognitive and behavioral impairments in infants exposed to this opioid during prenatal development.
And for adults:
Additionally, we observed a significant reduction in synaptic density in mature neurons
Technical part:
In animal models, prenatal methadone exposure results in detrimental consequences to the central nervous system, such as: (i) increased neuronal apoptosis; (ii) disruption of oligodendrocyte maturation and increased apoptosis and (iii) increased microglia and astrocyte activation. However, it remains unclear whether these deleterious effects result from a direct effect of methadone on brain cells. Therefore, our goal was to uncover the impact of methadone on single brain cell types in vitro. Primary cultures of rat neurons, oligodendrocytes, microglia, and astrocytes were treated for three days with 10 µM methadone to emulate a chronic administration. Apoptotic neurons were identified by cleaved caspase-3 detection, and synaptic density was assessed by the juxtaposition of presynaptic and postsynaptic markers. Apoptosis of oligodendrocyte precursors was determined by cleaved caspase-3 detection. Oligodendrocyte myelination was assessed by immunofluorescence, while microglia and astrocyte proinflammatory activation were assessed by both immunofluorescence and RT-qPCR. Methadone treatment increased neuronal apoptosis and reduced synaptic density. Furthermore, it led to increased oligodendrocyte apoptosis and a reduction in the myelinating capacity of these cells, and promoted the proinflammatory activation of microglia and astrocytes.
Conclusion part:
We showed that methadone, the most widely used drug in opioid replacement therapy for pregnant women with opioid addiction, directly impairs brain cells in vitro, highlighting the need for developing alternative therapies to address opioid addiction in this population.
In sum, the presented evidence suggest that therapies aimed to reduce the negative consequences of opioid substitution therapy (methadone toxicity) would need to address a direct central effect of methadone on neurons, oligodendrocytes, microglia, and astrocytes, emphasizing the importance of finding new pharmacotherapies for maternal OUD (opioid use disorder)
(original study)
Last edited:
